Home > NewsRelease > Coronaphobia: Good News About the Coronavirus
Text
Coronaphobia: Good News About the Coronavirus
From:
Charles Page MD -- Texas-based Surgeon, Author, Storyteller Charles Page MD -- Texas-based Surgeon, Author, Storyteller
For Immediate Release:
Dateline: Nacogdoches , TX
Thursday, August 20, 2020

 

Good news. Here’s some updates on Coronavirus and a recent commentary from the Orlando Medical News.

https://youtu.be/9wlyT3qtgRc

One interesting fact about the Coronavirus death rate. It’s much less that what was anticipated. One of the challenging aspects is determing the death rate. If you use the confirmed number of cases (that’s about 5.4 million in the US) the mortality rate is < 3 %.

If, however you consider the unconfirmed cases the mortality rate goes much lower. (< 1 %). Last month the CDC began checking for COVID antibodies in blood samples unconfirmed cases. These were patients who had blood drawn for other reasons. They found that many of these patients already had antibodies to the virus. They are estimating the number of unconfirmed cases may be 2 to 13% higher. So it’s really hard to tell exactly how many total cases we have in the US. The Good news is this: The Pandemci is not as bad as we anticipated.

This is good news. Let’s keep going.

Here’s some more articles for those of you who are interested. https://www.pharmaceutical-journal.com/news-and-analysis/research-briefing/covid-19-death-rate-under-1-when-unconfirmed-cases-considered-researchers-estimate/20207886.article

Here’s the CDC article: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/about-serology-surveillance.html

However you choose to crunch the numbers, the death rate is less than we thought.

News Media Interview Contact
Name: Jerry McGlothlin
Group: Special Guests
Dateline: Hickory, NC United States
Direct Phone: 919-437-0001
Jump To Charles Page MD -- Texas-based Surgeon, Author, Storyteller Jump To Charles Page MD -- Texas-based Surgeon, Author, Storyteller
Contact Click to Contact
Other experts on these topics